The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial (446150)
ARTG Name
OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial
Product name
OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
ocrelizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information